Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteines

Virology

Volumn 393, Issue 2, 2009, Pages 295-303

  Conway, Michael J ^a   Alam, Samina ^a   Christensen, Neil D ^a   Meyers, Craig ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Assembly; Capsid; Organotypic culture; Papillomavirus; Redox

Indexed keywords

CAPSID PROTEIN; CAPSID PROTEIN L2; CYSTEINE; EPITOPE; NEUTRALIZING ANTIBODY; SERINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; CRYOELECTRON MICROSCOPY; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN STRUCTURE; VIRION; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; WILD TYPE;

AMINO ACID SUBSTITUTION; CAPSID PROTEINS; CELL LINE; CYSTEINE; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; MUTAGENESIS, SITE-DIRECTED; NEUTRALIZATION TESTS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; VIRION;

HUMAN PAPILLOMAVIRUS TYPE 16; MIRIDAE; PAPILLOMAVIRIDAE;

EID: 70349840682     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.08.010     Document Type: Article

References (43)

1. Bordeaux J., Forte S., Harding E., Darshan M.S., Klucevsek K., and Moroianu J. The l2 minor capsid protein of low-risk human papillomavirus type 11 interacts with host nuclear import receptors and viral DNA. J. Virol. 80 16 (2006) 8259-8262
2. Bossis I., Roden R.B., Gambhira R., Yang R., Tagaya M., Howley P.M., and Meneses P.I. Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection. J. Virol. 79 11 (2005) 6723-6731
3. Buck C.B., Pastrana D.V., Lowy D.R., and Schiller J.T. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 78 2 (2004) 751-757
4. Buck C.B., Thompson C.D., Pang Y.Y., Lowy D.R., and Schiller J.T. Maturation of papillomavirus capsids. J. Virol. 79 5 (2005) 2839-2846
5. Buck C.B., Cheng N., Thompson C.D., Lowy D.R., Steven A.C., Schiller J.T., and Trus B.L. Arrangement of L2 within the papillomavirus capsid. J. Virol. (2008)
6. Campos S.K., and Ozbun M.A. Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes. PLoS ONE 4 2 (2009) e4463
7. Chen X.S., Garcea R.L., Goldberg I., Casini G., and Harrison S.C. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell 5 3 (2000) 557-567
8. Conway, M.J., Alam, S., Ryndock, E.J., Cruz, L., Christensen, N.D., Roden, R.B.S., Meyers, C., in press. Tissue-spanning redox gradient-dependent assembly of native HPV16 virions. J. Virol.
9. Conway M.J., and Meyers C. Replication and assembly of human papillomaviruses. J. Dental Res. 88 4 (2009) 307-317
10. Culp T.D., and Christensen N.D. Quantitative RT-PCR assay for HPV infection in cultured cells. J. Virol. Methods 111 2 (2003) 135-144
11. Day P.M., Baker C.C., Lowy D.R., and Schiller J.T. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl. Acad. Sci. U.S.A. 101 39 (2004) 14252-14257
12. Day P.M., Gambhira R., Roden R.B., Lowy D.R., and Schiller J.T. Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies. J. Virol. 82 9 (2008) 4638-4646
13. Day P.M., Lowy D.R., and Schiller J.T. Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids. J. Virol. 82 24 (2008) 12565-12568
14. Doorbar J. The papillomavirus life cycle. J. Clin. Virol. 32 Suppl. 1 (2005) S7-S15
15. Doorbar J., and Gallimore P.H. Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a. J. Virol. 61 9 (1987) 2793-2799
16. Finnen R.L., Erickson K.D., Chen X.S., and Garcea R.L. Interactions between papillomavirus L1 and L2 capsid proteins. J. Virol. 77 8 (2003) 4818-4826
17. Gambhira R., Karanam B., Jagu S., Roberts J.N., Buck C.B., Bossis I., Alphs H., Culp T., Christensen N.D., and Roden R.B. A protective and broadly cross-neutralizing epitope of human papillomavirus L2. J. Virol. 81 24 (2007) 13927-13931
18. Holmgren S.C., Patterson N.A., Ozbun M.A., and Lambert P.F. The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J. Virol. 79 7 (2005) 3938-3948
19. Ishii Y., Tanaka K., and Kanda T. Mutational analysis of human papillomavirus type 16 major capsid protein L1: the cysteines affecting the intermolecular bonding and structure of L1-capsids. Virology 308 1 (2003) 128-136
20. Ishii Y., Ozaki S., Tanaka K., and Kanda T. Human papillomavirus 16 minor capsid protein L2 helps capsomeres assemble independently of intercapsomeric disulfide bonding. Virus Genes 31 3 (2005) 321-328
21. Kirnbauer R., Taub J., Greenstone H., Roden R., Durst M., Gissmann L., Lowy D.R., and Schiller J.T. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67 12 (1993) 6929-6936
22. Kondo K., Ishii Y., Ochi H., Matsumoto T., Yoshikawa H., and Kanda T. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Virology 358 2 (2007) 266-272
23. Li M., Beard P., Estes P.A., Lyon M.K., and Garcea R.L. Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly. J. Virol. 72 3 (1998) 2160-2167
24. Liu W.J., Gissmann L., Sun X.Y., Kanjanahaluethai A., Muller M., Doorbar J., and Zhou J. Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology 227 2 (1997) 474-483
25. Longworth M.S., and Laimins L.A. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68 2 (2004) 362-372
26. Lowe J., Panda D., Rose S., Jensen T., Hughes W.A., Tso F.Y., and Angeletti P.C. Evolutionary and structural analyses of alpha-papillomavirus capsid proteins yields novel insights into L2 structure and interaction with L1. Virol. J. 5 1 (2008) 150
27. Mach H., Volkin D.B., Troutman R.D., Wang B., Luo Z., Jansen K.U., and Shi L. Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs). J. Pharm. Sci. 95 10 (2006) 2195-2206
28. McLaughlin-Drubin M.E., and Meyers C. Propagation of infectious, high-risk HPV in organotypic "raft" culture. Methods Mol. Med. 119 (2005) 171-186
29. McLaughlin-Drubin M.E., Wilson S., Mullikin B., Suzich J., and Meyers C. Human papillomavirus type 45 propagation, infection, and neutralization. Virology 312 1 (2003) 1-7
30. McLaughlin-Drubin M.E., Christensen N.D., and Meyers C. Propagation, infection, and neutralization of authentic HPV16 virus. Virology 322 2 (2004) 213-219
31. Meyers C., Frattini M.G., Hudson J.B., and Laimins L.A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257 5072 (1992) 971-973
32. Meyers C., Mayer T.J., and Ozbun M.A. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 71 10 (1997) 7381-7386
33. Pyeon D., Lambert P.F., and Ahlquist P. Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 102 26 (2005) 9311-9316
34. Richards R.M., Lowy D.R., Schiller J.T., and Day P.M. Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc. Natl. Acad. Sci. U.S.A. 103 5 (2006) 1522-1527
35. Sapp M., Fligge C., Petzak I., Harris J.R., and Streeck R.E. Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines. J. Virol. 72 7 (1998) 6186-6189
36. Smith L.H., Foster C., Hitchcock M.E., Leiserowitz G.S., Hall K., Isseroff R., Christensen N.D., and Kreider J.W. Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro. J. Investig. Dermatol. 105 (1995) 438-444
37. Smith J.L., Campos S.K., and Ozbun M.A. Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes. J. Virol. 81 18 (2007) 9922-9931
38. Touze A., Mahe D., El Mehdaoui S., Dupuy C., Combita-Rojas A.L., Bousarghin L., Sizaret P.Y., and Coursaget P. The nine C-terminal amino acids of the major capsid protein of the human papillomavirus type 16 are essential for DNA binding and gene transfer capacity. FEMS Microbiol. Lett. 189 1 (2000) 121-127
39. Trus B.L., Roden R.B., Greenstone H.L., Vrhel M., Schiller J.T., and Booy F.P. Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution. Nat. Struct. Biol. 4 5 (1997) 413-420
40. Wang H.K., Duffy A.A., Broker T.R., and Chow L.T. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 23 2 (2009) 181-194
41. White W.I., Wilson S.D., Bonnez W., Rose R.C., Koenig S., and Suzich J.A. In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16. J. Virol. 72 2 (1998) 959-964
42. Yang R., Day P.M., Yutzy W.H.t., Lin K.Y., Hung C.F., and Roden R.B. Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J. Virol. 77 6 (2003) 3531-3541
43. Zhou J., Sun X.Y., Louis K., and Frazer I.H. Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence. J. Virol. 68 2 (1994) 619-625